Sandoz Group (OTCMKTS:SDZNY) Trading Down 1.3% – What’s Next?

Sandoz Group AG (OTCMKTS:SDZNY) was down 1.3% during trading on Tuesday . The stock traded as low as $38.06 and last traded at $39.72. Approximately 63,481 shares traded hands during mid-day trading, an increase of 49% from the average daily volume of 42,556 shares. The stock had previously closed at $40.23.

Wall Street Analysts Forecast Growth

Separately, UBS Group cut shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 3rd.

Sandoz Group Trading Down 1.3 %

The stock’s 50-day simple moving average is $42.34 and its two-hundred day simple moving average is $43.61.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.